ATHA NASDAQ

Athira Pharma, Inc. - Common Stock

Healthcare · Pharmaceuticals
$5.88
▲ +$0.21 (+3.70%)
Vol 18K
2
Quality Score
fail
Mkt Cap
$29.9M
ROE
-107.1%
D/E
0.00
Beta
2.86
52W
$2–$8

Price Chart

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -139.4% -139.4% -139.4% -139.4% -107.1% -107.1%
P/E (TTM)
Net Margin
Gross Margin
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 10.81 10.81 10.81 10.81 9.70 9.70

Key Ratios

ROA (TTM)
-89.9%
P/B
0.5
EPS (TTM)
$-9.68
CF/Share
$-3.15
52W High
$8.36
52W Low
$2.19
$2.19 52-Week Range $8.36

How does ATHA compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

ATHA AARD ACB ACRS ADIL

ATHA valuation vs Pharmaceuticals peers

P/E ratio
0% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
0.5
76% below peers (2.1)
vs Peers
vs Industry
Undervalued
Div yield
0% below peers (2.0%)
vs Peers
vs Industry
Low yield

ATHA profitability vs Pharmaceuticals peers

ROE
-107.1%
97% below peers (-54.3%)
vs Peers
vs Industry
Weak
Net margin
0% below peers (-47.4%)
vs Peers
vs Industry
Top tier
Gross margin
0% below peers (68.3%)
vs Peers
vs Industry
In line
ROA
-89.9%
140% below peers (-37.4%)
vs Peers
vs Industry
Weak

ATHA financial health vs Pharmaceuticals peers

D/E ratio
0.0
100% below peers (1.5)
vs Peers
vs Industry
Low debt
Current ratio
9.7
189% above peers (3.4)
vs Peers
vs Industry
Strong liquidity
Beta
2.9
205% above peers (0.9)
vs Peers
vs Industry
More volatile

ATHA fundamentals radar

ATHA Peer median Industry

ATHA profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

ATHA vs peers: key metrics